These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
955 related articles for article (PubMed ID: 9484276)
1. The management of ductal carcinoma in situ (DCIS). The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists. CMAJ; 1998 Feb; 158 Suppl 3():S27-34. PubMed ID: 9484276 [TBL] [Abstract][Full Text] [Related]
2. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists. CMAJ; 1998 Feb; 158 Suppl 3():S3-8. PubMed ID: 9484272 [TBL] [Abstract][Full Text] [Related]
3. Follow-up after treatment for breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ; 1998 Feb; 158 Suppl 3():S65-70. PubMed ID: 9484280 [TBL] [Abstract][Full Text] [Related]
4. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up. Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650 [TBL] [Abstract][Full Text] [Related]
5. Optimal management of ductal carcinoma in situ of the breast. Sakorafas GH; Farley DR Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563 [TBL] [Abstract][Full Text] [Related]
6. Ductal carcinoma in situ (DCIS) of the breast: evolving perspectives. Sakorafas GH; Tsiotou AG Cancer Treat Rev; 2000 Apr; 26(2):103-25. PubMed ID: 10772968 [TBL] [Abstract][Full Text] [Related]
7. Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis. Boyages J; Delaney G; Taylor R Cancer; 1999 Feb; 85(3):616-28. PubMed ID: 10091735 [TBL] [Abstract][Full Text] [Related]
8. Influence of local treatment on the recurrence rate of ductal carcinoma in situ. Warneke J; Grossklaus D; Davis J; Stea B; Bebb G; Taylor C; Hastings R; Villar H J Am Coll Surg; 1995 Jun; 180(6):683-8. PubMed ID: 7773481 [TBL] [Abstract][Full Text] [Related]
9. Treatment of ductal carcinoma in situ of the breast: review of recent advances and future prospects. Mokbel K Int J Fertil Womens Med; 2003; 48(5):217-25. PubMed ID: 14626378 [TBL] [Abstract][Full Text] [Related]
10. Predictors of surgical margin status in breast-conserving surgery within a breast screening program. Kurniawan ED; Wong MH; Windle I; Rose A; Mou A; Buchanan M; Collins JP; Miller JA; Gruen RL; Mann GB Ann Surg Oncol; 2008 Sep; 15(9):2542-9. PubMed ID: 18618180 [TBL] [Abstract][Full Text] [Related]
11. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge. Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063 [TBL] [Abstract][Full Text] [Related]
12. Contemporary treatment of ductal carcinoma in situ of the breast. Mokbel K Med Sci Monit; 2005 Mar; 11(3):RA86-93. PubMed ID: 15735580 [TBL] [Abstract][Full Text] [Related]
13. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery. Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108 [TBL] [Abstract][Full Text] [Related]
14. Effect of margin status on local recurrence after breast conservation and radiation therapy for ductal carcinoma in situ. Dunne C; Burke JP; Morrow M; Kell MR J Clin Oncol; 2009 Apr; 27(10):1615-20. PubMed ID: 19255332 [TBL] [Abstract][Full Text] [Related]
15. Ductal carcinoma in situ of the breast: correlation of pathologic and mammographic features with extent of disease. Coombs JH; Hubbard E; Hudson K; Wunderlich C; VanMeter S; Bell JL; Gwin JL Am Surg; 1997 Dec; 63(12):1079-83. PubMed ID: 9393256 [TBL] [Abstract][Full Text] [Related]
16. Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy. Adepoju LJ; Symmans WF; Babiera GV; Singletary SE; Arun B; Sneige N; Pusztai L; Buchholz TA; Sahin A; Hunt KK; Meric-Bernstam F; Ross MI; Ames FC; Kuerer HM Cancer; 2006 Jan; 106(1):42-50. PubMed ID: 16333852 [TBL] [Abstract][Full Text] [Related]
17. Breast-conserving surgery with or without radiotherapy in women with ductal carcinoma in situ: a meta-analysis of randomized trials. Viani GA; Stefano EJ; Afonso SL; De Fendi LI; Soares FV; Leon PG; GuimarĂ£es FS Radiat Oncol; 2007 Aug; 2():28. PubMed ID: 17683529 [TBL] [Abstract][Full Text] [Related]
18. Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies. Lagios MD; Silverstein MJ Surg Oncol Clin N Am; 1997 Apr; 6(2):385-92. PubMed ID: 9115503 [TBL] [Abstract][Full Text] [Related]
19. [The treatment of ductal carcinoma in situ (DCIS) of the breast]. Westenberg AH; Rutgers EJ; Peterse JL; Hendriks JH; Beex LV; van Tienhoven G Ned Tijdschr Geneeskd; 2003 Nov; 147(44):2157-61. PubMed ID: 14626831 [TBL] [Abstract][Full Text] [Related]
20. Accuracy of intraoperative gross examination of surgical margin status in women undergoing partial mastectomy for breast malignancy. Balch GC; Mithani SK; Simpson JF; Kelley MC Am Surg; 2005 Jan; 71(1):22-7; discussion 27-8. PubMed ID: 15757052 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]